Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
England’s NICE Defends Its Processes, But Recognizes ‘Tough’ Climate For Industry
Nov 07 2025
•
By
Eliza Slawther
Lawrence Tallon, MHRA CEO and Sam Roberts, NICE CEO, in London, UK, 2025
(Pink Sheet)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from United Kingdom